Evidence map›Paper›PMID 18570415›Full record

ArticleJournal of the American Chemical Society2008

Proton-sponge coated quantum dots for siRNA delivery and intracellular imaging.

Maksym V Yezhelyev, Lifeng Qi, Ruth M O'Regan, Shuming Nie, Xiaohu Gao

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 108 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
108citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

108 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Synthesis of PEG-grafted boron doped Si nanocrystals.The Journal of chemical physics · 2019
    Article
  20. Review

48 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Maksym V YezhelyevWinship Cancer Institute, Emory University, Atlanta, Georgia 30322, USA.
Lifeng Qi
Ruth M O'Regan
Shuming Nie
Xiaohu Gao

Funding

Tissue and Animal UseU54CA119338 · NCI · EMORY UNIVERSITY · PI BAO, GANG · 2005 to 2009
$18.4M
Nanotechnology: Detection &Analysis of Plaque FormationU01HL080711 · NHLBI · EMORY UNIVERSITY · PI BAO, GANG · 2005 to 2009
$11.0M
Nanotechnology Linking Biomarkers with Cancer BehaviorR01CA108468 · NCI · EMORY UNIVERSITY · PI NIE, SHUMING · 2004 to 2008
$6.9M
Bioaffinity Nanoparticle Probes for Bioimaging (RMI)P20GM072069 · NIGMS · EMORY UNIVERSITY · PI NIE, SHUMING · 2004 to 2007
$2.6M
Sensitive and multiplexed analysis of cancer biomarkers with QD barcodesR01CA131797 · NCI · UNIVERSITY OF WASHINGTON · PI GAO, XIAOHU · 2008 to 2012
$1.6M
NCI NIH HHS R01 CA108468NCI NIH HHS R01 CA131797NCI NIH HHS U54 CA119338NCI NIH HHS U54CA119338NHLBI NIH HHS U01 HL080711NHLBI NIH HHS U01HL080711NIGMS NIH HHS P20 GM072069
6 · The paper itself

Abstract

We report the rational design of multifunctional nanoparticles for short-interfering RNA (siRNA) delivery and imaging based on the use of semiconductor quantum dots (QDs) and proton-absorbing polymeric coatings (proton sponges). With a balanced composition of tertiary amine and carboxylic acid groups, these nanoparticles are specifically designed to address longstanding barriers in siRNA delivery such as cellular penetration, endosomal release, carrier unpacking, and intracellular transport. The results demonstrate dramatic improvement in gene silencing efficiency by 10-20-fold and simultaneous reduction in cellular toxicity by 5-6-fold, when compared directly with existing transfection agents for MDA-MB-231 cells. The QD-siRNA nanoparticles are also dual-modality optical and electron-microscopy probes, allowing real-time tracking and ultrastructural localization of QDs during delivery and transfection. These new insights and capabilities represent a major step toward nanoparticle engineering for imaging and therapeutic applications.

Indexed as

Quantum DotsAnimalsCell Line, TumorCyclophilinsHumansMiceModels, MolecularNanoparticlesNIH 3T3 CellsPeptidylprolyl IsomeraseProtonsRNA, Small InterferingTransfectioncyclophilin BCyclophilinsPeptidylprolyl IsomeraseProtonsRNA, Small Interfering

Identifiers

PMID18570415
PMCPMC2621273

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.